Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Abstract Text:

    j-m mosqueraJ-M Mosquera,s pernerS Perner,f demichelisF Demichelis,r kimR Kim,m d hoferM D Hofer,k d mertzK D Mertz,p l parisP L Paris,j simkoJ Simko,c collinsC Collins,t a bismarT A Bismar,a m chinnaiyanA M Chinnaiyan,m a rubinM A Rubin,

    The TMPRSS2-ETS fusion prostate cancers comprise 50-70% of the prostate-specific antigen (PSA)-screened hospital-based prostate cancers examined to date, making it perhaps the most common genetic rearrangement in human cancer. The most common variant involves androgen-regulated TMPRSS2 and ERG, both located on chromosome 21. Emerging data from our group and others suggests that TMPRSS2-ERG fusion prostate cancer is associated with higher tumour stage and prostate cancer-specific death. The goal of this study was to determine if this common somatic alteration is associated with a morphological phenotype. We assessed 253 prostate cancer cases for TMPRSS2-ERG fusion status using an ERG break-apart FISH assay. Blinded to gene fusion status, two reviewers assessed each tumour for presence or absence of eight morphological features. Statistical analysis was performed to look for significant associations between morphological features and TMPRSS2-ERG fusion status. Five morphological features were associated with TMPRSS2-ERG fusion prostate cancer: blue-tinged mucin, cribriform growth pattern, macronucleoli, intraductal tumour spread, and signet-ring cell features, all with p-values < 0.05. Only 24% (n=30/125) of tumours without any of these features displayed the TMPRSS2-ERG fusion. By comparison, 55% (n=38/69) of cases with one feature (RR=3.88), 86% (n=38/44) of cases with two features (RR=20.06), and 93% (n=14/15) of cases with three or more features (RR=44.33) were fusion positive (p<0.001). To our knowledge, this is the first study that demonstrates a significant link between a molecular alteration in prostate cancer and distinct phenotypic features. The strength of these findings is similar to microsatellite unstable colon cancer and breast cancer involving BRCA1 and BRCA2 mutations. The biological effect of TMPRSS2-ERG overexpression may drive pathways that favour these common morphological features that pathologists observe daily. These features may also be helpful in diagnosing TMPRSS2-ERG fusion prostate cancer, which may have both prognostic and therapeutic implications.

    Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Publishing Authors By Initials

    jm mosqueraJM Mosquera,s pernerS Perner,f demichelisF Demichelis,r kimR Kim,md hoferMD Hofer,kd mertzKD Mertz,pl parisPL Paris,j simkoJ Simko,c collinsC Collins,ta bismarTA Bismar,am chinnaiyanAM Chinnaiyan,ma rubinMA Rubin,

    For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

    PUBMED ID PMID:

    MEDLINE DATE:

    Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of pathology

    VOLUME: 212

    Page Numbers: 91-101

    Journal Abbreviation: J. Pathol.

    ISSN: 0022-3417

    DAY: 3

    MONTH: May

    YEAR: 2007

    Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 204634

    Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Keywords Mesh Terms:

    KEYWORDS: Tumor Markers, Biological

    MESH TERMS: analysis

    Chemical & Substance for Abstract: Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Information

    Substance Name: TMPRSS2 protein, human

    Registry Number: EC 3.4.21.-

    Grant and Affiliation Information for Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

    AFFILIATION: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115-6110, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: U01 CA113913

    ACRONYM: CA

    MEDLINETA: J Pathol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Morphological features of TMPRSS2-ERG gene fusion prostate cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News